0

Global Glaucoma Therapeutics Market 2017-2021

  • Published: Oct 2017
  • Pages: 97
  • SKU: IRTNTR15263
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

This market research study identifies Allergan, Pfizer, Novartis, and Merck as the leading players in the global glaucoma therapeutics market. A comprehensive analysis of this market is also presented by drug class (prostaglandin analogs, beta blockers, alpha agonists, carbonic anhydrase inhibitors, and others) and by geography (the Americas, APAC, and EMEA).

Overview of the global glaucoma therapeutics market

Technavio’s market research report has identified the advent of new innovative combination drugs to be one of the primary factors driving the growth of the glaucoma therapeutics market till 2021. To control the elevated intraocular pressure (IOP), healthcare physicians recommend a combination of two or more drugs for about 40%-45% of the glaucoma patients. According to clinical studies , the prescription of fixed combination therapies for glaucoma is more effective in lowering IOP than individual therapeutic agents. Moreover, the prescription of fixed combination also simplifies the medical regimen. Cosopt (timolol/dorzolamide), combigan (timolol/brimonidine), xalacom (timolol/latanoprost), ganfort (timolol/bimatoprost), and duotrav (timolol/travoprost) are the common combination drugs used for glaucoma. Technavio’s market research analysts estimate that this market will register a revenue of more than USD 8 billion by 2021.

The emergence of new drug delivery techniques such as the adoption of various strategies to provide the drug with a carrier to hold the drug on the surface of the cornea for a longer duration benefits patients by reducing the frequency of doses. This will in turn, improve the patients’ adherence and compliance to the medication. According to our market research analysts, the emergence of new drug delivery methods will be one of the key trends that will gain traction in the glaucoma therapeutics market during the next few years.

Competitive landscape and key vendors

The glaucoma therapeutics market is characterized by the presence of key companies and the vendors compete against each other mainly based on factors such as product efficacy, prolonged action, limited side effects, rich pipeline, and operational base. The players in this marketspace are increasingly focusing on launching novel therapies and are investing heavily in R&D activities to improve their market positions.

Key vendors in this market are -

  • Allergan
  • Pfizer
  • Novartis
  • Merck

Other prominent vendors in the market include Bayer HealthCare, Akorn, Bausch & Lomb, Santen Pharmaceutical, Teva Pharmaceutical, and VISTAKON.

Segmentation by drug class and analysis of the glaucoma therapeutics market

  • Prostaglandin analogs
  • Beta blockers
  • Alpha agonists
  • Carbonic anhydrase inhibitors

The prostaglandin analogs segment accounted for the majr shares of the glaucoma therapeutics market during 2016. Prostaglandin analogs are extensively adopted for the treatment of open-angle glaucoma since they are more effective than the other drugs. Latanoprost, bimatoprost, travoprost, and tafluprost are the four prostaglandin analogs that are available in the market for the treatment of glaucoma. It has been observed that the administration of tafluprost, travoprost, and latanoprost has shown an IOP-lowering ability of 25%-32% during clinical trials. Similarly, bimatoprost showed IOP-lowering ability of 27%-32%.

Segmentation by geography and analysis of the glaucoma therapeutics market

  • Americas
  • APAC
  • EMEA

The consumption of glaucoma drugs in the Americas is increasing due to the rising incidence of glaucoma in countries such as the US. Owing to its heavy investments in the healthcare sector, the US the major revenue contributor to the glaucoma therapeutics market in this region. With the presence of pharmaceutical giants and huge investments in the pharmaceutical industry, the need for glaucoma therapeutics will increase in the region during the predicted period.

Key questions answered in the report include

  • What will the glaucoma therapeutics market size and the growth rate be in 2021?
  • What are the key factors driving the global glaucoma therapeutics market?
  • What are the key glaucoma therapeutics market trends impacting the growth of the market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global glaucoma therapeutics market?
  • What are the market opportunities and threats faced by the vendors in the global glaucoma therapeutics market?
  • What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
  • What are the key outcomes of the five forces analysis of the global glaucoma therapeutics market?

Technavio also offers customization on reports based on specific client requirement.

PART 01: EXECUTIVE SUMMARY

PART 02: RESEARCH METHODOLOGY

PART 03: INTRODUCTION

  • Market outline

PART 04: MARKET LANDSCAPE

  • Market overview
  • Five forces analysis

PART 05: PIPELINE LANDSCAPE

PART 06: MARKET SEGMENTATION BY DRUG CLASS

  • Global glaucoma therapeutics market by prostaglandin analogs
  • Global glaucoma therapeutics market by beta blockers
  • Global glaucoma therapeutics market by alpha agonists
  • Global glaucoma therapeutics market by carbonic anhydrase inhibitors
  • Global glaucoma therapeutics market by others

PART 07: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas – market size and forecast
  • EMEA – market size and forecast
  • APAC – market size and forecast
  • Market opportunity

PART 08: DECISION FRAMEWORK

PART 09: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

  • Competitive scenario

PART 12: KEY VENDOR ANALYSIS

  • Allergan
  • Pfizer
  • Novartis
  • Merck
  • Other prominent vendors

PART 13: APPENDIX

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your sample now!
  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?
  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis

Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Safe and Secure SSL Encrypted
Technavio

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Customized Report as per your Business Needs

  • Our analysts will work directly with you and understand your needs
  • Get data on specified regions or segments, competitor and Vendors
  • Data will be formatted and presented as per your requirements
  • We offer $1000 worth of FREE customization at the time of purchase

Let us help you make report more suited to your requirements.

  • Get a competitive breakdown as per your niche industry
  • Customize the data with various metrics that meet your business prerequisite
  • Understand Revenue Sources, Customers and many more
  • Details on Market Share
  • These customizations are done in a short amount of time by our analysts and industry experts
Technavio
Enquire Before Buying
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>